Not Signed In -
Mitotane |
Lysodren |
Image:Mitotane.png Mitotane Systematic (IUPAC) name 1-chloro-2-[2,2-dichloro-1-(4-chlorophenyl)-ethyl]-benzene Identifiers CAS number 53-19-0 ATC code L01XX23 PubChem 4211 DrugBank APRD00494 Chemical data Formula C14H10Cl4 Mol. weight 320.04 g/mol Pharmacokinetic data Bioavailability ? Protein binding 6% Metabolism ? Half life 18-159 days Excretion ? Therapeutic considerations Pregnancy cat. ? Legal status Routes ? Mi ...
Wikipedia - [full article]
Mitotane Clinical Trials
- Evaluation of Side Effects of Mitotane
ClinicalTrials.gov Identifier: NCT00568139 - Not yet recruiting
Adrenocortical Carcinoma
- Tariquidar, Mitotane, Doxorubicin, Vincristine, and Etoposide Plus Surgery in Treating Patients With Recurrent, Metastatic, or Primary Unresectable Adrenocortical Cancer
ClinicalTrials.gov Identifier: NCT00073996 - Recruiting
Adrenocortical Carcinoma
- Surgery Plus Chemotherapy (Doxorubicin, Vincristine and Etoposide), Mitotane, and Tariquidar to Treat Adrenocortical Cancer
ClinicalTrials.gov Identifier: NCT00071058 - Recruiting
Adrenal Cortex Neoplasms
- Trial in Locally Advanced and Metastatic Adrenocortical Carcinoma Treatment (FIRM-ACT)
ClinicalTrials.gov Identifier: NCT00094497 - Recruiting
Carcinoma, Adrenal Cortical
- A Study of Combination Chemotherapy and Surgical Resection in the Treatment of Adrenocortical Carcinoma: Continuous Infusion Doxorubicin, Vincristine and Etoposide with Daily Mitotane Before and After Surgical Resection
ClinicalTrials.gov Identifier: NCT00001339 - Completed
Adrenal Cortical Carcinoma
email this page
print this page
bookmark this page
feedback on this page
